Eric Chau, PA
Physician Assistant · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 2 carriers
- Offices
- 2
Offices
2 locations · Khurram Abbass MD Inc · 5 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
3 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Eric Chau’s office at (408) 684-4104 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
3 of 3 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Drugs they prescribed that Part D paid
$332,497
Pharmacies billed $332,497 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 400) in 2024. At or below the middle of the specialty; the typical physician assistant clinician is at 1%.
333 generic and 67 brand-name prescriptions · $332,497 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Enbrel Sureclick | 18 | $148,126 | $8,229 |
| Leflunomide | 31 | $2,281 | $74 |
| Hydroxychloroquine Sulfate | 45 | $969 | $22 |
| Methotrexate | 53 | $707 | $13 |
| Colchicine | 14 | $520 | $37 |
See all 10 drugs
| Enbrel Sureclick | 18 | $148,126 | $8,229 |
| Leflunomide | 31 | $2,281 | $74 |
| Hydroxychloroquine Sulfate | 45 | $969 | $22 |
| Methotrexate | 53 | $707 | $13 |
| Colchicine | 14 | $520 | $37 |
| Alendronate | 54 | $512 | $9 |
| Diclofenac | 25 | $427 | $17 |
| Allopurinol | 29 | $181 | $6 |
| Prednisone | 32 | $86 | $3 |
| Gabapentin | 12 | $86 | $7 |
Year by year
| 2024 | 400 | 169 | 0% (0) | 17% | $332,497 |
| 2023 | 35 | None | 0% (0) | 34% | $5,818 |
| 2022 | 18 | None | 0% (0) | None | $2,205 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Money from drug and device companies
$2,357 in 2025
| 2025 | 17 | 104 | None | $2,357 |
| 2024 | 15 | 45 | None | $1,085 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Rinvoq | $608 | 27 payments
|
| Amgen | Evenity | $376 | 18 payments
|
| Ucb | Bimzelx | $191 | 8 payments
|
| Radius Health | Tymlos | $189 | 10 payments
|
| GlaxoSmithKline | Benlysta | $174 | 7 payments
|
| Aurinia Pharma U.S. | Lupkynis | $158 | 8 payments
|
See all 99 published payments
| Abbvie | Meals · 2025-12-30 | Rinvoq | $29 |
| ANI Pharmaceuticals | Meals · 2025-12-30 | Purified Cortrophin Gel | $14 |
| Abbvie | Meals · 2025-12-21 | Rinvoq | $2 |
| Radius Health | Meals · 2025-12-15 | Tymlos | $32 |
| Abbvie | Meals · 2025-11-25 | Rinvoq | $7 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-11-25 | Saphnelo | $18 |
| Aurinia Pharma U.S. | Meals · 2025-11-25 | Lupkynis | $27 |
| Amgen | Meals · 2025-11-18 | Evenity | $29 |
| GlaxoSmithKline | Meals · 2025-11-17 | Benlysta | $19 |
| Abbvie | Meals · 2025-10-31 | Rinvoq | $14 |
| GlaxoSmithKline | Meals · 2025-10-30 | Benlysta | $26 |
| Abbvie | Meals · 2025-10-30 | Rinvoq | $1 |
| Abbvie | Meals · 2025-10-29 | Rinvoq | $8 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-28 | Saphnelo | $22 |
| Gilead Sciences | Meals · 2025-10-22 | None | $132 |
| Radius Health | Meals · 2025-10-22 | Tymlos | $24 |
| Ucb | Meals · 2025-10-21 | Bimzelx | $22 |
| Amgen | Meals · 2025-10-14 | Otezla | $29 |
| ANI Pharmaceuticals | Meals · 2025-09-29 | Purified Cortrophin Gel | $28 |
| GlaxoSmithKline | Meals · 2025-09-24 | Benlysta | $18 |
| Abbvie | Meals · 2025-09-24 | Rinvoq | $27 |
| Amgen | Meals · 2025-09-22 | Evenity | $31 |
| Amgen | Meals · 2025-09-11 | Tavneos | $19 |
| Aurinia Pharma U.S. | Meals · 2025-09-10 | Lupkynis | $25 |
| Abbvie | Meals · 2025-09-04 | Rinvoq | $27 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-02 | Saphnelo | $20 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-08-26 | Orencia | $23 |
| Radius Health | Meals · 2025-08-21 | Tymlos | $22 |
| Radius Health | Meals · 2025-08-21 | Tymlos | $3 |
| Amgen | Meals · 2025-08-20 | Evenity | $17 |
| Pfizer | Meals · 2025-08-19 | Xeljanz | $29 |
| Mallinckrodt Hospital Products | Meals · 2025-08-18 | Acthar | $27 |
| Alexion Pharmaceuticals | Meals · 2025-08-12 | Strensiq | $30 |
| Amgen | Meals · 2025-08-11 | Otezla | $7 |
| Amgen | Meals · 2025-08-05 | Evenity | $29 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-21 | Saphnelo | $19 |
| Amgen | Meals · 2025-07-15 | Otezla | $21 |
| Abbvie | Meals · 2025-07-14 | Rinvoq | $6 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-14 | Saphnelo | $41 |
| Abbvie | Meals · 2025-07-10 | Rinvoq | $24 |
| Abbvie | Meals · 2025-07-10 | Rinvoq | $125 |
| Radius Health | Meals · 2025-07-09 | Tymlos | $23 |
| GlaxoSmithKline | Meals · 2025-07-08 | Benlysta | $31 |
| Amgen | Meals · 2025-06-24 | Krystexxa | $28 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-06-19 | Saphnelo | $23 |
| Amgen | Meals · 2025-06-16 | Tavneos | $13 |
| Abbvie | Meals · 2025-06-15 | Rinvoq | $12 |
| GlaxoSmithKline | Meals · 2025-06-12 | Benlysta | $30 |
| Abbvie | Meals · 2025-06-12 | Rinvoq | $19 |
| Ucb | Meals · 2025-06-11 | Bimzelx | $35 |
| Radius Health | Meals · 2025-06-09 | Tymlos | $24 |
| Aurinia Pharma U.S. | Meals · 2025-06-06 | Lupkynis | $20 |
| Abbvie | Meals · 2025-05-29 | Skyrizi | $2 |
| Abbvie | Meals · 2025-05-29 | Skyrizi | $20 |
| GlaxoSmithKline | Meals · 2025-05-20 | Benlysta | $28 |
| Celltrion USA | Meals · 2025-05-16 | Vegzelma | $23 |
| Ucb | Meals · 2025-05-14 | Bimzelx | $6 |
| Abbvie | Meals · 2025-05-13 | Rinvoq | $4 |
| Ucb | Meals · 2025-05-13 | Bimzelx | $37 |
| Amgen | Meals · 2025-05-13 | Evenity | $17 |
| Aurinia Pharma U.S. | Meals · 2025-05-06 | Lupkynis | $26 |
| Abbvie | Meals · 2025-05-02 | Rinvoq | $29 |
| Abbvie | Meals · 2025-05-02 | Rinvoq | $4 |
| Abbvie | Meals · 2025-05-01 | Rinvoq | $19 |
| Abbvie | Meals · 2025-04-28 | Rinvoq | $14 |
| Radius Health | Meals · 2025-04-28 | Tymlos | $23 |
| Pfizer | Meals · 2025-04-24 | Xeljanz | $34 |
| GlaxoSmithKline | Meals · 2025-04-22 | Benlysta | $23 |
| Amgen | Meals · 2025-04-21 | Krystexxa | $25 |
| Amgen | Meals · 2025-04-10 | Otezla | $23 |
| Abbvie | Meals · 2025-04-09 | Rinvoq | $28 |
| Amgen | Meals · 2025-04-03 | Tavneos | $19 |
| Abbvie | Meals · 2025-04-01 | Rinvoq | $13 |
| Aurinia Pharma U.S. | Meals · 2025-03-25 | Lupkynis | $26 |
| Radius Health | Meals · 2025-03-17 | Tymlos | $14 |
| Radius Health | Meals · 2025-03-17 | Tymlos | $2 |
| Abbvie | Meals · 2025-03-11 | Rinvoq | $12 |
| Celltrion USA | Meals · 2025-03-06 | Vegzelma | $32 |
| Abbvie | Meals · 2025-03-05 | Rinvoq | $8 |
| Genentech USA | Meals · 2025-03-04 | Actemra | $34 |
| Aurinia Pharma U.S. | Meals · 2025-02-25 | Lupkynis | $23 |
| Ucb | Meals · 2025-02-24 | Bimzelx | $22 |
| Pfizer | Meals · 2025-02-18 | Xeljanz | $32 |
| Abbvie | Meals · 2025-02-17 | Rinvoq | $12 |
| Ucb | Meals · 2025-02-11 | Cimzia | $30 |
| Amgen | Meals · 2025-02-10 | Otezla | $10 |
| Abbvie | Meals · 2025-02-06 | None | $116 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-02-05 | Orencia | $25 |
| Amgen | Meals · 2025-01-30 | Tavneos | $10 |
| Ucb | Meals · 2025-01-27 | Bimzelx | $10 |
| Amgen | Meals · 2025-01-23 | Otezla | $24 |
| Amgen | Meals · 2025-01-21 | Krystexxa | $25 |
| Abbvie | Meals · 2025-01-17 | Rinvoq | $29 |
| Radius Health | Meals · 2025-01-15 | Tymlos | $23 |
| Sobi | Meals · 2025-01-09 | Kineret | $26 |
| Novartis Pharmaceuticals | Meals · 2025-01-08 | Ilaris | $29 |
| Ucb | Meals · 2025-01-08 | Bimzelx | $27 |
| Aurinia Pharma U.S. | Meals · 2025-01-07 | Lupkynis | $4 |
| Aurinia Pharma U.S. | Meals · 2025-01-07 | Lupkynis | $7 |
See earlier years (2024)
2024: $1,085
| Abbvie | Rinvoq | $314 | 16 payments
|
| Amgen | Enbrel | $177 | 10 payments
|
| Gilead Sciences | Vemlidy | $125 | 1 payment
|
| Ucb | Cimzia | $106 | 4 payments
|
| Fresenius Kabi USA | Tyenne | $58 | 2 payments
|
| Aurinia Pharma U.S. | Lupkynis | $53 | 2 payments
|
| Pfizer | Xeljanz | $45 | 2 payments
|
| Radius Health | Tymlos | $32 | 1 payment
|
| Kiniksa Pharmaceuticals International plc | Arcalyst | $30 | 1 payment
|
| Alexion Pharmaceuticals | Strensiq | $27 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Saphnelo | $26 | 1 payment
|
| Ultragenyx Pharmaceutical | Crysvita | $25 | 1 payment
|
| ANI Pharmaceuticals | Purified Cortrophin Gel | $23 | 1 payment
|
| Celltrion USA | Vegzelma | $23 | 1 payment
|
| Sobi | Kineret | $21 | 1 payment
|
Professional record
- NPI
- 1568944668
- Licence
- CA PA63937
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X); Federal specialty code 106S00000X (106S00000X); Student in a training program (390200000X)
- Mailing address
- 3611 Hageman Ave, Oakland, CA, 94619
- NPI first listed
- 2018-09-05
- NPI last updated
- 2025-01-08
- NPI record certified
- 2025-01-08
This is when the NPI record was last certified, not a medical board exam.